A generative AI platform that recommends consumer electronics based on expert knowledge. An algorithm that interprets the context of a consumer’s natural language query for product recommendations and derives weighted importance scores for product performance attributes.
EZIT
We develop natural human-robot interaction technologies and are building a companion robot that uses music to respond to people’s daily lives and emotions. By understanding user context and atmosphere, it proactively plays music and generates or edits it through conversation, aiming to make AI hardware a beloved everyday brand.
EyeGene, Inc.
EyeGene is a KOSDAQ listed clinical stage biotechnology company based in Korea involved in the research and development of innovative bio-pharmaceutical products. 1) mRNA SARS-COV-2 vaccine is currently being developed with cationic liposome delivery technology. 2) Herpes zoster vaccine is being used to develop a wide range of premium prophylactic vaccines as using own novel immune adjuvant technology(Herpes zoster, HPV etc.). 3) Treatments for ischemic diseases are currently being developed with advanced recombinant protein technology. 4) mRNA personalized cancer vaccines are being developed. Development status of our lead candidates: 1) EG-COVID(mRNA SARS-COV-2 vaccine, Phase 1/2a in Korea, Australia and South Africa). 2) EG-HZ(Herpes Zoster Vaccine, Phase I in Australia complete), EG-HPV (HPV Vaccine, Korea, Phase I complete) 3) EG-Mirotin (DME with Diabetic Retinopathy, EU and Korea, Phase IIa), EG-Decorin (Pressure Ulcer/Bedsore, Korea, Phase I/II and Wound healing, Korea, Phase II), EG-Myocin(Myocardial Ischemia/Reperfusion Injury, Korea, Phase II) EG-COVID(mRNA SARS-COV-2 vaccine, using own novel immune adjuvant technology) currently is undergoing Phase 1/2a clinical trial in Korea and Australia. We are also looking for licensing partners for global territorial rights for this pipeline. EG-HZ Vaccine consists of VZV glycoprotein E + CIA09A. CIA09A is one of our proprietary adjuvant systems. It will stimulate suitable immune system for people who have weakened immunity. It is completed Phase I clinical trial in Australia(2021). EG-Mirotin (therapeutic agent for Diabetic Retinopathy) completed Phase 2a trials in EU and Korea . We are looking for licensing partners for global territorial rights. EG-Decorin’s domestic territorial rights have been licensed out to Huons respectively (leading pharmaceutical companies in Korea). We are actively looking for licensing partners for global regions ex-Korea. EG-Myocin (therapeutic agent for Myocardial Ischemia/Reperfusion Injury) currently is undergoing Phase II clinical trial in Korea. We are also looking for licensing partners for global territorial rights for this pipeline. EG-HPV consists of Virus Like Particles (VLPs) + CIA06 (immune adjuvant). It is completed Phase I clinical trial in Korea.
EXoPERT
EXoPERT is a liquid biopsy diagnostics company developing an exosome-based platform that integrates SERS technology with AI-driven analysis. Using blood samples, our approach enables multi-cancer detection through comprehensive molecular profiling of exosomes for pre-screening and future clinical applications. | EXoPERT is a biotech company focusing on detecting cancer early by liquid biopsy. Founded in 2018, EXoPERT is developing a Novel Liquid biopsy technology(MCED) that detects cancer at an early stage, and we aim to expand our impact in healthcare through continued research and development.
EXIONLabs Inc
EXIONLabs is a digital healthcare startup that enhances the safety and efficiency of pharmacy dispensing with robotics and AI. Backed by the founder’s global experience, we develop solutions that address persistent challenges in real pharmacy settings and move toward a future in which healthcare is safer and more reliable for everyone.
exbody company Ltd.
For over a decade, exbody Co., Ltd. has been a pioneer in the field of data-based ‘personalized exercise therapy and fitness interaction solutions’. In Korea, we established a strong market presence long before the industry took shape and have solidified our position as the No.1 brand in musculoskeletal examination and posture analysis.
EX HEALTHCARE INC.
EX Healthcare is a pioneering company specializing in medical AI solutions, developing applications that utilize artificial intelligence to enhance diagnostic accuracy and improve patient care. Founded with the mission of integrating technology with health, we strive to bring advanced healthcare solutions directly to patients worldwide.
EverySim Inc.
Everysim Inc. is a cutting-edge technology startup founded in 2023, specializing in engineering simulation software solutions. We provide cloud-based SaaS platforms that utilize CFD (Computational Fluid Dynamics) and FEA (Finite Element Analysis) technologies to optimize the performance of aerospace, drone, and environmental applications.